Westlake Precision Birth Cohort

Study acronym: WeBirth
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Nov 30, 2025 to Apr 30, 2024
    • Study completion pushed from Aug 31, 2029 to Aug 31, 2035
    • Site details revised
    • Eligibility criteria expanded, about 4 words
  2. Re-verified, no change to tracked fieldsv8
  3. Primary completion date: Aug 31, 2023 to Nov 30, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 2000 to confirmed 2001
    • Site details revised
    v7
  4. Phase: Not specified to Not applicable
    • Secondary endpoints revised (3)
    • Study description shortened, about 7 words
    • Eligibility criteria shortened, about 2 words
    v6
  5. Primary completion date: Jul 11, 2022 to Aug 31, 2023
    • Study completion date: Jul 11, 2029 to Aug 31, 2029
    • Site details revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Collaborator revisedv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  3. Secondary endpoints: details revised at 1 of 3 entries
    • Eligibility criteria expanded, about 1 word
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Westlake University
13 trials monitored
See 2 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
The Westlake Precision Birth Cohort (WeBirth) is a prospective cohort study among women with hyperglycemia during pregnancy and their offspring living in Hangzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with gestational diabetes mellitus (GDM) over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of WeBirth is to investigate the association of dietary intake and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the participants with long-term metabolic health of these women and their offspring.
Trial Details
NCT Number NCT04060056
Lead Sponsor Westlake University
Collaborators: Hangzhou Maternal and Child Health Hospital
Conditions
(from sponsor)		 Diabetes, Gestational, Pregnancy in Diabetics, Intrauterine Hyperglycemia
Related terms Diabetes, Gestational, Pregnancy in Diabetics
Enrollment 2,001 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov